-
Tomorrow’s TrialsNew tools are being integrated into the research process to ease patients' access to clinical trials and improve their experience.
by Bradley Jones
-
Forward Look
What’s Next? Winter 2018/2019Off-the-shelf equivalents to CAR-T cell therapy are emerging.
by Bradley Jones
-
From the Editor-in-Chief
Improving Health After TreatmentThe U.S. health care system must adapt to the needs of cancer survivors.
by William G. Nelson, MD, PhD
-
2018 SABCS: Choosing the Right TreatmentStudies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.
by Kate Yandell
-
Treating Cancer Based on Its Genetics, Not Its LocationMedical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.
by Anna Azvolinsky
-
Reinforcements for Cancer ResearchScientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
by Marci A. Landsmann
-
Guiding CareMedical oncologist Gabrielle Rocque explains the role of clinical practice guidelines in breast cancer care.
by Anna Azvolinsky
-
Does Medicaid Expansion Have an Impact?Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
by Marci A. Landsmann
-
Achieving Health EqualityNational Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.
by Marci A. Landsmann
-
An Uncommon PartnershipThrough the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
